全文获取类型
收费全文 | 747426篇 |
免费 | 38827篇 |
国内免费 | 874篇 |
专业分类
耳鼻咽喉 | 9564篇 |
儿科学 | 23631篇 |
妇产科学 | 16979篇 |
基础医学 | 123753篇 |
口腔科学 | 17674篇 |
临床医学 | 65848篇 |
内科学 | 143142篇 |
皮肤病学 | 17631篇 |
神经病学 | 53525篇 |
特种医学 | 26269篇 |
外国民族医学 | 152篇 |
外科学 | 105230篇 |
综合类 | 8515篇 |
现状与发展 | 2篇 |
一般理论 | 168篇 |
预防医学 | 58921篇 |
眼科学 | 16178篇 |
药学 | 56897篇 |
1篇 | |
中国医学 | 1796篇 |
肿瘤学 | 41251篇 |
出版年
2021年 | 7169篇 |
2019年 | 7547篇 |
2018年 | 12697篇 |
2017年 | 8733篇 |
2016年 | 9476篇 |
2015年 | 10466篇 |
2014年 | 12449篇 |
2013年 | 19095篇 |
2012年 | 30646篇 |
2011年 | 32519篇 |
2010年 | 17485篇 |
2009年 | 14373篇 |
2008年 | 28667篇 |
2007年 | 31246篇 |
2006年 | 29639篇 |
2005年 | 28843篇 |
2004年 | 27647篇 |
2003年 | 25997篇 |
2002年 | 24919篇 |
2001年 | 27767篇 |
2000年 | 28405篇 |
1999年 | 23760篇 |
1998年 | 6015篇 |
1997年 | 5035篇 |
1996年 | 5028篇 |
1995年 | 4713篇 |
1992年 | 17291篇 |
1991年 | 18427篇 |
1990年 | 18444篇 |
1989年 | 17931篇 |
1988年 | 16477篇 |
1987年 | 16237篇 |
1986年 | 15104篇 |
1985年 | 14445篇 |
1984年 | 10681篇 |
1983年 | 9109篇 |
1982年 | 4803篇 |
1979年 | 10067篇 |
1978年 | 7169篇 |
1977年 | 5878篇 |
1976年 | 6095篇 |
1975年 | 7359篇 |
1974年 | 8343篇 |
1973年 | 8068篇 |
1972年 | 7456篇 |
1971年 | 7158篇 |
1970年 | 6658篇 |
1969年 | 6307篇 |
1968年 | 5902篇 |
1967年 | 5254篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
103.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
104.
Frédéric Janvier Deborah Delaune Thomas Poyot Eric Valade Audrey Mérens Pierre E. Rollin Vincent Foissaud 《Emerging infectious diseases》2016,22(2):292-294
We evaluated RNA stability of Ebola virus in EDTA blood and urine samples collected from infected patients and stored in West Africa’s environmental conditions. In blood, RNA was stable for at least 18 days when initial cycle threshold values were <30, but in urine, RNA degradation occurred more quickly. 相似文献
105.
106.
Imre W.K. Kouw Bart B.L. Groen Joey S.J. Smeets Irene Fleur Kramer Janneau M.X. van Kranenburg Rachél Nilwik Jan A.P. Geurts René H.M. ten Broeke Martijn Poeze Luc J.C. van Loon Lex B. Verdijk 《Journal of the American Medical Directors Association》2019,20(1):35-42
Objectives
Short successive periods of skeletal muscle disuse have been suggested to substantially contribute to the observed loss of skeletal muscle mass over the life span. Hospitalization of older individuals due to acute illness, injury, or major surgery generally results in a mean hospital stay of 5 to 7 days, during which the level of physical activity is strongly reduced. We hypothesized that hospitalization following elective total hip arthroplasty is accompanied by substantial leg muscle atrophy in older men and women.Design and participants
Twenty-six older patients (75 ± 1 years) undergoing elective total hip arthroplasty participated in this observational study.Measurements
On hospital admission and on the day of discharge, computed tomographic (CT) scans were performed to assess muscle cross-sectional area (CSA) of both legs. During surgery and on the day of hospital discharge, a skeletal muscle biopsy was taken from the m. vastus lateralis of the operated leg to assess muscle fiber type–specific CSA.Results
An average of 5.6 ± 0.3 days of hospitalization resulted in a significant decline in quadriceps (?3.4% ± 1.0%) and thigh muscle CSA (?4.2% ± 1.1%) in the nonoperated leg (P < .05). Edema resulted in a 10.3% ± 1.7% increase in leg CSA in the operated leg (P < .05). At hospital admission, muscle fiber CSA was smaller in the type II vs type I fibers (3326 ± 253 μm2 vs 4075 ± 279 μm2, respectively; P < .05). During hospitalization, type I and II muscle fiber CSA tended to increase, likely due to edema in the operated leg (P = .10).Conclusions
Six days of hospitalization following elective total hip arthroplasty leads to substantial leg muscle atrophy in older patients. Effective intervention strategies are warranted to prevent the loss of muscle mass induced by short periods of muscle disuse during hospitalization. 相似文献107.
108.
Sissa Brito dos Santos Aurélia Bertholet-Thomas Marine Butin Laurence Dubourg Alain Fouilhoux Justine Bacchetta 《Archives de pédiatrie》2021,28(4):338-341
The main clinical features of tyrosinemia type 1 usually appear in the first months of life, including fever, diarrhea, vomiting, liver involvement, growth failure, and renal proximal tubulopathy with subsequent hypophosphatemic rickets. An early diagnosis is crucial in order to provide specific management and to prevent complications. Here, we report on two cases referred primarily to pediatric nephrologists for the diagnosis of “neonatal tubulopathy” and management of “X-linked hypophosphatemia (XLH),” respectively. Our aim is to emphasize that (1) even a mixed tubulopathy can reveal tyrosinemia, and (2) tyrosinemia is a classic differential diagnosis of XLH that should not be forgotten, especially in the era of the anti-FGF23 burosumab. 相似文献
109.
110.